Meeting
2018 ASCO Annual Meeting
IDH-wild type low grade gliomas: An AINO (Italian Association of Neuro-Oncology) retrospective study.
Authors
Roberta Ruda
Department of Neuro-Oncology, University of Turin and City of Health and Science, Turin, Italy
Roberta Ruda , Francesco Bruno , Antonio Silvani , Tamara Ius , Lorenzo Bello , Giuseppe Minniti , Andrea Pace , Giuseppe Lombardi , Riccardo Soffietti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2050)
DOI
10.1200/JCO.2018.36.15_suppl.2050
Abstract #
2050
Poster Bd #
208
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
RANO 2.0: Proposal for an update to the Response Assessment in Neuro-Oncology (RANO) Criteria for high- and low-grade gliomas in adults.
First Author: Patrick Y. Wen
Poster
2019 ASCO Annual Meeting
EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma.
First Author: Patrick Roth
Poster
2018 ASCO Annual Meeting
A large, multicenter, retrospective study to identify a cutoff of MGMT methylation status by quantitative pyrosequencing approach in patients (PTS) with glioblastoma (GBM).
First Author: Giuseppe Lombardi
Poster
2018 ASCO Annual Meeting
Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2.
First Author: Tobias Kessler